ArticleBiochemistry and biophysics reports2025
Micronized purified flavonoid fraction (daflon) improves sexual function by modulating NF-kB /NO/cGMP and steroidogenic signaling in cisplatin-treated male Wistar rats.
Article in Biochemistry and biophysics reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Diacerein mitigates cisplatin-induced testicular toxicity in rats; Role of Nrf2/ HO-1, NF-κB/caspase-3 and NLRP3/ASC/Caspase-1 signaling pathways.Molecular biology reports · 2026Article
- Effects of MDMA treatment and cessation on sexual behaviour and testicular functions in male sprague-dawley rats.BMC pharmacology & toxicology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cisplatin is known to induce sexual dysfunction by suppressing testosterone levels. It also upregulates nuclear factor-kappa B (NF-kB), which mediates nitric oxide (NO)-dependent endothelial dysfunction. This study evaluated the effects of daflon, a micronized purified flavonoid fraction that contains diosmin and hesperidin, on the NF-kB/NO/cyclic guanosine monophosphate (cGMP) and steroidogenic signaling pathways in cisplatin-induced male sexual dysfunction. Thirty-two male Albino Wistar rats were randomly assigned to four groups: vehicle-treated, daflon-treated, cisplatin-treated, and cisplatin plus daflon-treated. Cisplatin administration resulted in impaired sexual function, characterized by prolonged latencies for mounting, intromission, and ejaculation, as well as a decrease in mating motivation and the frequencies of these behaviors. Additionally, cisplatin reduced sperm quality and downregulated NO/cGMP levels through the upregulation of NF-kB and MDA and downregulation of GSH, which is critical for maintaining endothelial function. Furthermore, cisplatin suppressed serum levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and inhibited the activities of testicular 3β-hydroxysteroid dehydrogenase (3β-HSD) and 17β-hydroxysteroid dehydrogenase (17β-HSD), leading to decreased serum testosterone and dopamine levels. Co-administration of daflon with cisplatin resulted in the downregulation of NF-kB and MDA and an increase in GSH, NO, and cGMP production. Daflon co-treatment also upregulated LH, FSH, 3β-HSD, and 17β-HSD, as well as circulating testosterone and dopamine levels, which corresponded with improved sexual function, evident from enhanced mating motivation and improved latencies and frequencies of mounting, intromission, and ejaculation. In conclusion, the daflon improved sexual function in rats treated with cisplatin. This involved the downregulation of NF-kB and enhancement of the cavernosal NO/cGMP pathway and testicular steroidogenic signaling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.